Terbaru 3
Terbaru 3
Terbaru 3
In the present study, each ABR wave was ders, organic mental disorders, other neuro-
carefully observed by increasing stimulus in- logical disorders, or hearing loss greater than
tensity, as the latter has a profound effect on 20 dBHL. Informed consent was obtained
ABR. Then the obtained findings were exam- from all the participants.
ined in relation to positive and negative symp-
toms of the patients as assessed by BPRS2* METHODS
and SANS’.
The patients’ clinical symptoms were as-
SUBJECTS sessed using BPRS and SANS by a psychia-
trist just before the present study. They were
Table 1 shows the characteristics of schizo- rated by the total score (T-BPRS), the positive
phrenic patients and normal subjects in this symptom cluster (P-BPRS; hallucinatory be-
study. The 30 schizophrenic patients, who havior, unusual thought content and suspi-
were hospitalized at the psychiatric ward of ciousness), the negative symptom cluster (N-
our university and at a private mental hospital, BPRS; blunted affect and emotional with-
were examined. They consisted of 19 males drawal) of the BPRS, and the total score of the
and 1 1 females. Their ages ranged from 17 to SANS (SANS).
46 (mean 31.8) and their duration of illness The ABR recordings were based on a minor
was from 6 months to 21 years (mean 9.1). revision of Pfefferbaum’ s method.23Ag/AgCl
The mean dosage of antipsychotic drugs was disk electrodes were attached to the vertex
534.5 mg (S.D.=330.4) in equivalent doses of (Cz), to the left or right mastoid for reference.
c h l o r p r ~ m a z i n eTheir
.~ diagnoses of schizo- and to the forehead for grounding. The imped-
phrenia according to DSM-111-R1 were: 10 ance of each electrode was checked to be less
cases disorganized, 4 catatonic, 8 paranoid, 4 than 5 kohms. The patients were instructed to
residual and 4 undifferentiated. Five were lie in a comfortable position with eyes closed
classified as subchronic, 14 as chronic, 3 as on an electrically shielded sheet placed on a
subchronic with acute exacerbation, 4 as bed. The following experiments were carried
chronic with acute exacerbation and 4 were in out using an evoked potential recorder system
remission by the classification of course (Neuropack 11, NIHONKOHDEN, JAPAN).
(DSM-111-R). Click stimuli (rectangular, 0.1-msec pulses)
Twenty-nine normal subjects ( 18 males and were delivered binaurally through an electro-
11 females), aged 24 to 46 (mean 29.3) were magnetically shielded headphone (TDH-49,
matched with the patients in age and gender Telephonics, U.S.A.) at a rate of S/sec. The
(Table 1). None of the patients and normal hearing thresholds to the click stimuli were
subjects had any histories of psychoactive tested for each ear and a stimulus intensity
substance-use disorders, developmental disor- paradigm delivered clicks at 60, 70 and 80
dBHL. In all the ABRs, positivity at the vertex
was recorded as an upward deflection. The re-
Table 1 : Characteristics of the Subjects sulting signal was delivered to a bandpass fil-
ter set at 20-3,000 Hz. The analysis time was
Sex Duration Dose of 10 msec after each stimulus and the sampling
Age of Illness Antipsychotic
M F (years) (years) Drugs*(rng) time was 20 psec. The averaged responses to
Schizophrenic Patients (n=30)
2,048 click stimuli were recorded and drawn
19 I 1 3 1.828.1 9.1k6.9 53452330.4 with an X-Y recorder. A typical ABR consists
Normal Subjects (n=29) of a series of waves, designated by the Roman
18 I I 29.3kS.3 ~ - numerals I, 11,111, IV and V within the first 10
’: D a i l y e q u i v a l e n t s of c h l o r p r o r n a r i n e a n d r e l a t e d ms after the onset of the stimulus.lS The ABR
antipsychotic drugs by Davis, J.M. (1976). amplitude rises linearly with increasing stimu-
Auditory Brainstem Responses in Schizophrenia 573
waves (the 1-11, 1-111, I-V, and 111-V IPIs). The peaks). The mean amplitude of each wave in
mean data of ABR measurements from both these groups and in the normal subjects is pre-
sides were used in the statistical analyses. The sented in Table 2. Group A showed signifi-
significance of any group differences was de- cantly lower amplitudes of wave I (t=2.36,
termined using the two-tailed t-test. p<0.05 by Student’s t-test), I11 (t=2.05, p<0.05
by Student’s t-test) and V (t=4.57, p<O.Ol by
RESULTS Student’s t-test) than the normal subjects,
while group B had a lower amplitude of wave
Fig. 2 shows a series of ABR waveforms V (t=2.09, p<0.05 by Welch’s t-test). The
from two schizophrenic patients, a man aged mean absolute latencies and IPIs in both
44 (A) and the other 41 (B). Wave I1 on the
left side in A and waves I and I1 on both sides
in B were not clearly evoked in spite of an in- Table 2: Amplitudes of Each ABR Wave in
crease in stimulus intensity to 80 dBHL. In B, the Schizophrenic Patients with One or More
these waves were not evoked at 90 dBHL ei- Missing Peaks (Group A) or without
ther. Waves I and I11 on the right side of one any Missing Peaks (Group B)
and in Normal Subjects
patient, wave I1 on the left side of four, wave
I1 on the right side of one, wave I1 on both Amplitude (vV)
sides of one and waves I and I1 on both sides
of one were not clearly evoked at 80 dBHL. I I1 I11 v
Wave I1 on both sides was lacking in one nor- Schizophrenics
mal subject. One or two peaks of ABR wave- Group A (n=8)
mean 0.15* - 0.36* 0.74**
forms were missing in 8 of the 30 schizo-
S.D. 0.03 - 0.13 0.15
phrenic patients (26.7%), but in one of the 29 Group B (n=22)
normal subjects (3.4%). This was a significant mean 0.25 0.38 0.44 0.94*
difference at the 0.05 level (x2=4.48, df=l, S.D. 0.09 0.17 0.16 0.29
p<0.05, after Yate’s correction). Normal Controls (n=29)
The patients were divided into group A mean 0.25 0.44 0.52 1.10
(n=8, those with one or more missing peaks) S.D. 0.10 0.19 0.18 0.20
and group B (n=22, those without any missing ’*: pcO.05, +*: p<O.Ol, compared to normal subjects
Table 3: Absolute Latencies and IPIs of Each ABR Wave in the Schizophrenic Patients with
One or More Missing Peaks (Group A) or without any Missing Peaks (Group B) and in Normal Subjects
_ _ _ _ ~ ~ ~ ~~ ____
Group A (n=8)
mean 33.0 10.5 599.2 55.1 11.9 10.3** 92.0’
S.D. 11.2 8.5 421.7 8.0 2.2 1.8 20.8
(n=3)
Group B (n=22)
mean 31.4 8.6 51 1 . 1 52.9 10.8 8.2 59.1
S.D. 6.5 6.2 286.6 12.7 3.4 1.7 18.7
(n=10)
9: dosage of antipsychotic drugs in equivalent doses of chlorpromazine (Davis 1976), *: assessment in 13 of 30 schizophrenic patients,
P-BPRS: BPRS positive symptom cluster (hallucinatory behavior, unusual thought content and suspiciousness), N-BPRS: BPRS negative
symptom cluster (blunted affect and emotional withdrawal).
*: p<0.05, **: p<O.OI, Group A vs. Group B
groups and in the normal subjects are given in groups A and B regarding the other clinical
Table 3. Group A showed a significantly features such as total doses of antipsychotic
shorter latency of wave I (t=3.33, p<O.Ol by drugs (599.2k421.7 vs.511.1+286.6mg,
Student’s t-test), and longer 1-111 (t=2.45, t=0.63,0.5cpcl by Student’s t-test).
pc0.05 by Student’s t-test) and I-V (t=3.16,
pcO.01 by Student’s t-test) IPIs than the nor- DISCUSSION
mal subjects. The prolonged I-V IPI was due
to the prolonged 1-111 IPI, as there was no sig- The above results indicate that at least one
nificant prolongation of the 111-V interval. of waves I, I1 or I11 was missing frequently
Group B had a significantly shorter latency of (27%) in the schizophrenic patients. This
wave I (t=2.09, pc0.05 by Welch’s t-test), I1 prevalence approximates that of other investi-
(t=2.57, pc0.05 by Welch’s t-test) and I11 gators, 50%19 and 38.5%*O in which the pa-
(t=2.73, pcO.01 by Student’s t-test) than the thology of absolute latencies or IPIs was in-
normal subjects. The reduced wave I1 and I11 cluded, or 32.5%’* of chronic schizophrenics
latencies were attributed to the reduced wave I selected by the Kraepelin Performance Test.
latency, because of no reduction of 1-11 and I- The prevalence of missing peaks (3.4%) in the
I11 IPIs. normal subjects was in agreement with that of
Table 4 shows the patients’ characteristics other studies.6 l 2
(age, duration of illness and total doses of The schizophrenic patients with one or
antipsychotic drugs) and symptom clusters more missing peaks had decreased amplitudes
(T-BPRS, P-BPRS, N-BPRS and SANS) of of all components and a prolonged 1-111 IPI.
the two schizophrenic groups. The N-BPRS This suggests these patients have a decrement
score was significantly higher in group A than in neuronal activity and/or asynchronization
in group B (t=2.77, pcO.01 by Student’s t-test) in the brainstem and slow transmission in the
and the same tendency (p=0.025 by Wilcoxon auditory pathway in the lower brainstem. The
rank-sum test) was seen in the SANS score. amplitude of evoked responses is thought to
There were no significant differences between reflect the degree of neuronal activities andor
S7h M. Igata et cil.
antipsychotic medication. Arch Gen Psychia- schizophrenic symptoms and the role of
try 33: 858-861, 1976. dopamine: Discussion, 1. Br J Psychiatry 137:
10. Fisman, M.: The brain stem in psychosis. Br J 379-383, 1980.
Psychiatry 126: 4 1 4 4 2 2 , 1975. 22. Overall, J.E. and Gorham, D.E.: The Brief
11. Freedman, R., Adler, L.E., Waldo, M.C., Psychiatric Rating Scale. Psychol Rep 10:
Pachtman, E. and Franks, R.D.: Neurophysi- 799-8 12, 1962.
ological evidence for a defect in inhibitory 23. Pfefferbaum, A , , Horvath, T.B., Roth, W.T.,
pathways in schizophrenia: Comparison of Tinklenberg, J.R. and Kopell, B.S.: Auditory
medicated and drug-free patients. Biol Psy- brain stem and cortical evoked potentials in
chiatry 18: 537-55 1, 1983. schizophrenia. Biol Psychiatry 15: 209-223,
12. Hayashida, Y., Mitani, Y., Hosomi, H. , 1980.
Amemiya, M., Mifune, K. and Tomita, S.: 24. Picton, T.W. and Hillyard, S.A.: Human audi-
Auditory brain stem responses in relation to tory evoked potentials. 11: Effect of attention.
the clinical symptoms of schizophrenia. Biol Electroencephalogr Clin Neurophysiol 36:
Psychiatry 21: 177-1 88, 1986. 191-199, 1974.
13. Iacono, W.G., Tuason, V.B. and Johnson, 25. Robinson, K. and Rudge, P.: Centrally gener-
R.A.: Dissociation of smooth-pursuit and sac- ated auditory potentials. In: Hlliday, A.M.
cadic eye tracking in remitted schizophrenics. (Ed.), Evoked potentials in clinical testing.
An ocular reaction time task that schizo- Churchill Livingstone Inc., New York, pp
phrenics perform well. Arch Gen Psychiatry 345-372, 1982.
38: 991-996, 1981. 26. Roemer, R.A., Chagass, C., Straumanis, J.J.
14. Jewett, D.L.: Volume-conducted potentials in and Amadeo, M.: Somatosensory and audi-
response to auditory stimuli as detected by tory evoked potential studies of functional
averaging in the cat. Electroencephalogr Clin differences between the cerebral hemispheres
Neurophysiol 28: 609-6 18, 1970. in psychosis. Biol Psychiatry 14: 357-373,
15. Jewett, D.L. and Williston, J.S.: Auditory- 1979.
evoked far fields averaged from the scalp of 27. Roth, W.T., Horvath, T.B., Pfefferbaum, A.
humans. Brain 94: 68 1-696, I97 1. and Kopell, B.S.: Event-related potentials in
16. Jones, A.M. and Pivik, R.T.: Abnormal vi- schizophrenics. Electroencephalogr Clin
sual-vestibular interactions in psychosis. Biol Neurophysiol48: 127-1 39, 1980.
Psychiatry 18: 45-61, 1983. 28. Schlor, K.H., Moises, H.W., Haas, S. and
17. Josiassen, R.C., Busk, J., Hart, A.D. and Rieger, H.: Schizophrenia, psychoticism,
Vanderploeg, R.: Early auditory information neuroleptics, and auditory evoked potentials.
processing in schizophrenia: A preliminary Pharmacopsychiatria 18: 293-296, 1985.
report. Biol Psychol 10: 225-234, 1980. 29. Shagass, C., Straumanis, J.J., Roemer, R.A.
18. Kimhi, R., Englender, M., Zohar, M. and and Amadeo, M.: Evoked potentials of
Harell, M.: Brainstem auditory evoked re- schizophrenics in several sensory modalities.
sponses in hospitalized unmedicated schizo- Biol Psychiatry 12: 221-235, 1977.
phrenic patients. Isr J Psychiatr Relat Sci 24: 30. Small, J.G., Milstein, V., Kellams, J.J. and
289-294, 1987. Small, I.F.: Auditory brain stem evoked re-
19. Lindstrom, L.H., Klockhoff, I., Svedberg, A. sponses in hospitalized patients undergoing
and Bergstrom, K.: Abnormal auditory brain- drug treatment or ECT. Biol Psychiatry 16:
stem responses in hallucinating schizophrenic 287-290, 198 1.
patients. Br J Psychiatry 151: 9-14, 1987. 31. Starr, A. and Hamilton, A.E.: Correlation be-
20. Lindstrom, L.H., Wieselgren, I.M., tween confirmed sites of neurological lesions
Klockhoff, I. and Svedberg, A,: Relationship and abnormalities of far-field auditory
between a b n o r m al brainstem au d i t o r y - brainstem responses. Electroencephalogr
evoked potentials and subnormal CSF levels Clin Neurophysiol41: 595-608, 1976.
of HVA and 5-HIAA in first-episode schizo- 32. Stevens, J.R.: Neuropathology of schizophre-
phrenic patients. Biol Psychiatry 28: 435- nia. Arch Gen Psychiatry 39: 1131-1 139,
442, 1990. 1982.
21. M a c k a y , A.V.P.: Positive and negative 33. Streletz, L.J., Katz, L., Hohenberger, M. and
578 M. Igata et al.
Cracco, R.Q.: Scalp recorded auditory evoked Peselow, E. and Cohen, N.: High thresholds
potentials and sonomotor responses: An for movement perception in schizophrenia
evaluation of components and recording may indicate abnormal extraneous noise lev-
techniques. Electroencephalogr Clin els of central vestibular activity. Biol Psy-
Neurophysiol43: 192-206, 1977. chiatry 20: 1197-1210, 1985.
34. Wertheim, A . H . , Gelder, P., Lautin, A,,